These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36093155)

  • 1. Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome.
    Yang J; Li K; Lv T; Xie Y; Liu F; Zhang P
    Front Cardiovasc Med; 2022; 9():992185. PubMed ID: 36093155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
    Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
    Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
    Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
    Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
    Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
    Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
    Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
    Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
    Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
    Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
    Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
    Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstetric management of a patient with Andersen-Tawil syndrome: A case report.
    Inagaki M; Tatsumi T; Yomogita H; Hirose A; Kubo T; Sekiguchi M; Miyasaka N
    J Obstet Gynaecol Res; 2021 Jan; 47(1):446-451. PubMed ID: 33205612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.
    Krych M; Biernacka EK; Ponińska J; Kukla P; Filipecki A; Gajda R; Hasdemir C; Antzelevitch C; Kosiec A; Szperl M; Płoski R; Trusz-Gluza M; Mizia-Stec K; Hoffman P
    J Cardiol; 2017 Nov; 70(5):504-510. PubMed ID: 28336205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular tachyarrhythmias in a patient with Andersen-Tawil syndrome.
    Pyo JY; Joh DH; Park JS; Lee SJ; Lee H; Kim W; Joung B
    Korean Circ J; 2013 Jan; 43(1):62-5. PubMed ID: 23407770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic ventricular tachycardia: diagnostic pitfalls of Andersen-Tawil syndrome-a case report.
    Nguyen D; Ferns SJ
    Eur Heart J Case Rep; 2018 Sep; 2(3):yty083. PubMed ID: 31020160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional Ventricular Tachycardia in a Young Female: A Case of Andersen-Tawil Syndrome.
    Ransom JL; Wong KC; Kircher J; Usry C; Larson C
    Mil Med; 2023 Jan; 188(1-2):e412-e416. PubMed ID: 33605413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andersen-Tawil syndrome with early fixed myopathy.
    Lefter S; Hardiman O; Costigan D; Lynch B; McConville J; Hand CK; Ryan AM
    J Clin Neuromuscul Dis; 2014 Dec; 16(2):79-82. PubMed ID: 25415519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
    Ergül Y; Özgür S; Onan SH; Tuzcu V
    Turk Kardiyol Dern Ars; 2018 Dec; 46(8):718-722. PubMed ID: 30516532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome.
    Ünal Yüksekgönül A; Azak E; Akalın A; Ertuğrul İ; Kılıç E; Utine GE; Karagöz T
    Eur J Med Genet; 2022 Jun; 65(6):104499. PubMed ID: 35429663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andersen-Tawil syndrome.
    Smith AH; Fish FA; Kannankeril PJ
    Indian Pacing Electrophysiol J; 2006 Jan; 6(1):32-43. PubMed ID: 16943893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
    Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
    Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional Ventricular Tachycardia and Prominent U Waves: Look at Fingers and Muscles and Use Flecainide.
    Oreto L; Briuglia S; Capra AP; Ruiz VG; Di Pino A
    J Pediatr Pharmacol Ther; 2023; 28(7):662-666. PubMed ID: 38025154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Loss-Of-Function
    Le Tanno P; Folacci M; Revilloud J; Faivre L; Laurent G; Pinson L; Amedro P; Millat G; Janin A; Vivaudou M; Roux-Buisson N; Fauré J
    Front Genet; 2021; 12():773177. PubMed ID: 34899860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
    Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
    Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.